Psychological outcomes following a nurse-led preventative psychological intervention for critically ill patients trial: Statistical and health economic analysis plan

Journal of the Intensive Care Society

Volumn 19, Issue 4, 2018, Pages 281-286

  Wulff, Jerome ^a   Sadique, Zia ^b   Grieve, Richard ^b   Howell, David ^c   Mouncey, Paul ^a   Wade, Dorothy ^c   Rowan, Kathryn M ^a   Harrison, David A ^a  

^a and London School of Hygiene Tropical Medicine   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Cognitive therapy; cost benefit analysis; critical care; post traumatic; statistics; stress disorders

Indexed keywords

ADULT; ARTICLE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; FEMALE; HUMAN; INTENSIVE CARE; MALE; NURSE; OUTCOME ASSESSMENT; REGISTRATION; STATISTICS; STRESS;

EID: 85054108894     PISSN: 17511437     EISSN: None     Source Type: Journal    
DOI: 10.1177/1751143718755016     Document Type: Article

References (26)

1. Ely EW, Inouye SK, Bernard GR, Delirium in mechanically ventilated patients – validity and reliability of the Confusion Assessment Method for the intensive care Unit (CAM-ICU). J Am Med Assoc 2001; 286: 2703–2710
2. Wade DM, Howell DC, Weinman JA, Investigating risk factors for psychological morbidity three months after intensive care: a prospective cohort study. Crit Care 2012; 16: R192
3. Finfer S, Bellomo R. Why publish statistical analysis plans? Crit Care Resusc 2009; 11: 5–6
4. Sessler CN, Gosnell MS, Grap MJ, The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166: 1338–1344
5. Wade DM, Hankins M, Smyth DA, Detecting acute distress and risk of future psychological morbidity in critically ill patients: validation of the intensive care psychological assessment tool. Crit Care 2014; 18: 519
6. Foa EB, Cashman L, Jaycox L, The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychol Assess 1997; 9: 445
7. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370
8. Herdman M, Gudex C, Lloyd A, Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20: 1727–1736
9. Carter BR, Hood K. Balance algorithm for cluster randomized trials. BMC Med Res Methodol 2008; 8: 65
10. White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 2010; 29: 2920–2931
11. Molenberghs G, Fitzmaurice G, Kenward MG, Handbook of missing data methodology, Boca Raton, FL: Chapman & Hall/CRC, 2015
12. Mason AJ, Gomes M, Grieve R, Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: application to the IMPROVE trial. Clin Trials 2017; 14: 357–367
13. Campbell MK, Piaggio G, Elbourne DR, Consort 2010 statement: extension to cluster randomised trials. BMJ 2012; 345: e5661
14. Maracy M, Dunn G. Estimating dose-response effects in psychological treatment trials: the role of instrumental variables. Stat Methods Med Res 2011; 20: 191–215
15. Department for Communities and Local Government. English indices of deprivation 2015, https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015 (2015, accessed 4 May 2017)
16. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992; 31: 301–306
17. Wang R, Lagakos SW, Ware JH, Statistics in medicine – reporting of subgroup analyses in clinical trials. N Engl J Med 2007; 357: 2189–2194
18. Oakley A, Strange V, Bonell C, Process evaluation in randomised controlled trials of complex interventions. BMJ 2006; 332: 413–416
19. Emsley R, Dunn G, White IR. Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res 2010; 19: 237–270
20. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal, London: National Institute for Health and Care Excellence, 2013
21. Curtis L. Unit costs of health & social care 2011, Canterbury: Personal Service Research Unit, University of Kent, 2011
22. Department of Health. NHS reference costs 2013–2014, London: Department of Health, 2014
23. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487–496
24. Grieve R, Nixon R, Thompson SG. Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials. Med Decis Making 2010; 30: 163–175
25. Green C, Dinnes J, Takeda AL, Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Int J Technol Assess Health Care 2006; 22: 90–100
26. Wright JC, Plenderleith L, Ridley SA. Long-term survival following intensive care: subgroup analysis and comparison with the general population. Anaesthesia 2003; 58: 637–642